Navigation Links
Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results
Date:1/25/2011

ssed by visiting the Johnson & Johnson website at www.investor.jnj.com. A replay and podcast will be available approximately two hours after the live webcast by visiting www.investor.jnj.com.

Copies of the financial schedules accompanying this press release are available at www.investor.jnj.com/historical-sales.cfm.  These schedules include supplementary sales data, a condensed consolidated statement of earnings, and sales of key products/franchises.  Additional information on Johnson & Johnson, including a pharmaceutical pipeline of selected compounds in late stage development and medical devices and diagnostics pipeline of selected products, can be found on the Company's website at www.investor.jnj.com.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's expectations and projections.  Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2010.  Copies
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
2. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
3. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
4. Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
5. Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer
6. Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business
7. Two-Time Super Bowl Champion Coach & Sports Broadcaster Jimmy Johnson Laughs About His Notoriety in New ExtenZe Spots from Inter/Media Advertising
8. Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnsons Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
9. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
10. Johnson & Johnson Completes Acquisition of Micrus Endovascular
11. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  Perrigo Company plc ("Perrigo") (NYSE: ... of "Quality Affordable Healthcare Products®," today announced the closing ... the sale of 6,809,210 ordinary shares at a public ... exercise of the option to purchase up to an ... and Barclays Capital Inc., as representatives of the several ...
(Date:11/26/2014)... Nov. 26, 2014 Lexicon Pharmaceuticals, Inc. ... completion of previously announced concurrent financing transactions resulting ... and estimated offering expenses, Lexicon anticipates net proceeds ... transactions consisted of: , a public ... to a registration statement that has been declared ...
(Date:11/26/2014)... , Nov. 26, 2014  Over 100 million ... those suffer from this pain daily. Chronic and acute ... pain management is born to fulfill the need for ... types of pain. On October 28th, a ... Cumberland, Maryland community.  This new ...
Breaking Medicine Technology:Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3New Pain Management Center Opens in Cumberland, Md. 2
... 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... LLY ) today announced results from a retrospective study ... incidence of events related to cardiovascular disease (CVD) and ... to initiators of other commonly used diabetes medications. These ...
... Reportlinker.com announces that a new market research report ... Global Agricultural Biotechnology Industry ... worldwide markets for Agricultural Biotechnology in US$ Million ... Corn, Cotton, & Others (Includes Canola, Wheat, Rice, ...
Cached Medicine Technology:Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 2Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 3Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 4Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 5Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 6Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia® 7Reportlinker Adds Global Agricultural Biotechnology Industry 2Reportlinker Adds Global Agricultural Biotechnology Industry 3Reportlinker Adds Global Agricultural Biotechnology Industry 4Reportlinker Adds Global Agricultural Biotechnology Industry 5Reportlinker Adds Global Agricultural Biotechnology Industry 6Reportlinker Adds Global Agricultural Biotechnology Industry 7Reportlinker Adds Global Agricultural Biotechnology Industry 8Reportlinker Adds Global Agricultural Biotechnology Industry 9Reportlinker Adds Global Agricultural Biotechnology Industry 10Reportlinker Adds Global Agricultural Biotechnology Industry 11Reportlinker Adds Global Agricultural Biotechnology Industry 12Reportlinker Adds Global Agricultural Biotechnology Industry 13Reportlinker Adds Global Agricultural Biotechnology Industry 14Reportlinker Adds Global Agricultural Biotechnology Industry 15Reportlinker Adds Global Agricultural Biotechnology Industry 16Reportlinker Adds Global Agricultural Biotechnology Industry 17Reportlinker Adds Global Agricultural Biotechnology Industry 18Reportlinker Adds Global Agricultural Biotechnology Industry 19Reportlinker Adds Global Agricultural Biotechnology Industry 20Reportlinker Adds Global Agricultural Biotechnology Industry 21Reportlinker Adds Global Agricultural Biotechnology Industry 22Reportlinker Adds Global Agricultural Biotechnology Industry 23Reportlinker Adds Global Agricultural Biotechnology Industry 24
(Date:11/27/2014)... 2014 Blood-borne pathogens raise the risk ... and procedures in place to counter this. However, it ... things tainted with menstrual blood are taken as seriously. ... more sanitary way to handle tampons and menstrual pads ... Sonora, Calif. , He then created a prototype of ...
(Date:11/27/2014)... Nov. 26, 2014 (HealthDay News) -- Most babies and ... cold, the U.S. Food and Drug Administration says. ... given to children younger than 2 because they could ... warned. American adults average about three colds a ... get a cold, parents might want to give them ...
(Date:11/27/2014)... November 27, 2014 Jeffrey Carlini ... in the Charlotte area providing audits, reviews, compilations, ... to businesses of varying size across numerous industries. ... to meet all of their accounting and tax ... the QuickBooks ProAdvisor Program. When asking Mr. Carlini ...
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “Wekho” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review ... locations instead of people. , An interesting new way to ... iOS and Android devices. It’s called Wekho and it’s ...
(Date:11/27/2014)... 2014 HealthPostures, a leading ... , has announced that it has entered into ... The partnership will put HealthPostures' products into central ... In addition to having its products sold through ... HealthPostures' products with the business decision makers in ...
Breaking Medicine News(10 mins):Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
... A Cochrane Systematic Review has concluded,Spraying salty water (saline) ... pain and congestion that accompany long-term infections of ... of people experience persistent infection of the nasal passages ... recommend spraying saline into the nose to relieve symptoms, ...
... (FDA) has approved the first artificial cervical (neck) disc for ... the most common causes of neck and arm pain. ... manufactured by Medtronic Sofamor Danek of Memphis. ,The ... degenerative disc disease now will have another surgical option for ...
... found that the chance of successfully quitting can be ... their stay, and then have at least one month ... in to hospital provides an opportunity to stop smoking. ... has to stop temporarily while in hospital. People who ...
... a dose of 20 mg per day can help people ... help prevent the weight gain that so often accompanies attempts ... was not shown to be effective. ,Smoking tobacco ... the endocannabinoid system, part of the hormonal control mechanism in ...
... that a chemical compound found in turmeric may help ... memory . ,Researchers isolated the compound 'bisdemethoxycurcumin' ... system cells that defend the body against infections and ... infuse this compound into patients and treat the incurable ...
... More than a year after President Bush unveiled a plan ... still has limited capacity to detect a disease outbreak ... has also decided that it will not close the borders ... Says Dr. Rajeev Venkayya, special assistant to the president for ...
Cached Medicine News:Health News:FDA Approves First Artificial Cervical Disc 2Health News:Hospital Provides an Oppurtunity to Quit Smoking 2Health News:20 Mg Rimonabant Per Day may Help to Quit Smoking 2Health News:Americas Preparations For Flu Outbreak Still Incomplete 2
Surgical drill bits, twist drills, HSS. Available in various sizes....
... When viewed through the enclosed ... provide a standard screening devise for ... tested. With normal stereo perception, the ... page in 3D. The test includes ...
... a versatile new test providing the broadest ... book. The Multi-Target Stereo test can be ... binocularity, stereopsis, visual attention, form and depth ... version includes a pair of high quality ...
... Stereotest consists of three test plates(6mm, 3mm, and ... a range of 600 - 15 seconds. No ... only be detected if stereopsis is present. Test ... of the patient learning the correct answer. Large ...
Medicine Products: